Abstract
Proteolytic enzymes have been implicated as the pathological agent in a number of disease states. For this reason proteases are attractive therapeutic targets. Phage display of peptide libraries can be used to identify peptides that may be used either directly as inhibitors or serve as leads in the generation of prodrugs and peptidomimetics.
Keywords: Phage Display, Protease Ligand, peptidomimetics, Plasma kallikrein, chymotrypsin, allosteric mechanism
Current Pharmaceutical Biotechnology
Title: Phage Display as a Tool for Protease Ligand Discovery
Volume: 3 Issue: 1
Author(s): Andrew E. Nixon
Affiliation:
Keywords: Phage Display, Protease Ligand, peptidomimetics, Plasma kallikrein, chymotrypsin, allosteric mechanism
Abstract: Proteolytic enzymes have been implicated as the pathological agent in a number of disease states. For this reason proteases are attractive therapeutic targets. Phage display of peptide libraries can be used to identify peptides that may be used either directly as inhibitors or serve as leads in the generation of prodrugs and peptidomimetics.
Export Options
About this article
Cite this article as:
Nixon E. Andrew, Phage Display as a Tool for Protease Ligand Discovery, Current Pharmaceutical Biotechnology 2002; 3 (1) . https://dx.doi.org/10.2174/1389201023378526
DOI https://dx.doi.org/10.2174/1389201023378526 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glycogen Phosphoprylase (EC 2.4.1.1) Activity During Cardiopulmonary Bypass in Patients Undergoing Cardiac Surgery
Vascular Disease Prevention (Discontinued) The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
Current Diabetes Reviews Zolpidem Arousing Effect in Persistent Vegetative State Patients: Autonomic, EEG and Behavioral Assessment
Current Pharmaceutical Design Duration of Dual Antiplatelet Therapy After Coronary Stenting
Current Pharmaceutical Design Cancer Chemoprevention by Targeting the Epigenome
Current Drug Targets Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Current Medicinal Chemistry Telephone Follow-up of Older People After Hospital Admissions
Current Aging Science Garlic (<i>Allium sativum</i> L.): Its Chemistry, Nutritional Composition, Toxicity, and Anticancer Properties
Current Topics in Medicinal Chemistry Design and Synthesis of Thiazolidinedione Derivates as Selective PPARγ Modulators
Letters in Drug Design & Discovery Recent Progress in Molecular Mechanisms of Angiotensin II Type 1 and 2 Receptors
Current Pharmaceutical Design Oxidative Stress, Antioxidants, and Endothelial Function
Current Medicinal Chemistry Postconditioning: A New Paradigm for Myocardial Protection?
Current Cardiology Reviews Modulation of Energy Intake and Expenditure Due to Habitual Physical Exercise
Current Pharmaceutical Design The Boundary between Hypochondriasis, Personality Dysfunction, and Trauma
Current Psychiatry Reviews Genomic and Non-genomic Effects of Aldosterone
Current Signal Transduction Therapy The Effect of Sex and Gender on Diabetic Complications
Current Diabetes Reviews Mesenchymal Stem Cell-derived Exosomes Rescue Oxygen-Glucose Deprivation-induced Injury in Endothelial Cells
Current Neurovascular Research Canonical Wnt/Beta-Catenin Signaling Network as Emerging Signaling Cascade for Therapeutic Intervention in Chronic Renal Disease
Current Drug Targets Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk
Current Pharmaceutical Design Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry